Author： Veltkamp Stephan Meerum Terwogt Jetske van den Heuvel Michel van Boven Hester Schellens Jan Rodenhuis Sjoerd
Publisher： Springer Publishing Company
ISSN： 0167-6997
Source： Investigational New Drugs, Vol.25, Iss.3, 2007-06, pp. : 279-281
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Docetaxel enhances gemcitabine for sarcoma, but adds toxicity
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
Access to resources
Recommend
Docetaxel plus gemcitabine shows antitumour efficacy in patients with advanced NSCLC
Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. :
Inpharma, Vol. 1, Iss. 1416, 2003-01 ,pp. :
Erlotinib/gemcitabine: Pulmonary toxicity in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1421, 2012-01 ,pp. :